Jushi Holdings (JUSHF) Intangibles (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Intangibles of $90.5 million for Q2 2026, down 6.68% year-over-year from $97.0 million in Q2 2025, and down 2.41% quarter-over-quarter from $92.8 million in Q1 2026.
Jushi Holdings (JUSHF) Intangibles (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Intangibles for 6 consecutive years, with $90.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Intangibles fell 6.68% year-over-year to $90.5 million; the TTM figure through Jun 2026 stood at $90.5 million (down 6.68% YoY), while the FY2025 annual figure was $92.2 million, down 8.23% from the prior year.
- Intangibles slipped to $90.5 million in Q2 2026 per JUSHF's latest filing, from $92.8 million in the prior quarter.
- Across five years, Intangibles topped out at $216.7 million in Q2 2022 and bottomed at $90.5 million in Q2 2026.
- Historically, Intangibles has averaged $113.0 million across 5 years, with a median of $97.3 million in 2023.
- Annual changes were most pronounced in 2023 — Intangibles plunged 54.57% — and 2024, when it rose 4.69%.
- Jushi Holdings' Intangibles stood at $100.1 million in 2022, then slipped by 4.11% to $96.0 million in 2023, then climbed by 4.69% to $100.5 million in 2024, then fell by 8.23% to $92.2 million in 2025, then dropped by 1.8% to $90.5 million in 2026.
- Business Quant data shows JUSHF's Intangibles at $90.5 million in Q2 2026, $92.8 million in Q1 2026, and $92.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 1.12 Bn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 90.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 90.54 Mn |
| Mar 31, 2026 | 92.78 Mn |
| Dec 31, 2025 | 92.21 Mn |
| Sep 30, 2025 | 94.80 Mn |
| Jun 30, 2025 | 97.02 Mn |
| Mar 31, 2025 | 98.91 Mn |
| Dec 31, 2024 | 100.47 Mn |
| Sep 30, 2024 | 91.92 Mn |
| Jun 30, 2024 | 94.02 Mn |
| Mar 31, 2024 | 95.22 Mn |
| Dec 31, 2023 | 95.97 Mn |
| Sep 30, 2023 | 97.62 Mn |
| Jun 30, 2023 | 98.47 Mn |
| Mar 31, 2023 | 99.15 Mn |
| Dec 31, 2022 | 100.08 Mn |
| Sep 30, 2022 | 178.22 Mn |
| Jun 30, 2022 | 216.74 Mn |
| Mar 31, 2022 | 199.93 Mn |
| Dec 31, 2021 | 192.47 Mn |